Danish trial to test semaglutide effects on trained runners' performance
The randomized placebo-controlled parallel study will measure muscle mass, muscle volume and function, running economy and performance during incretin-induced caloric restriction.
PR
By Priya Raman · Science Reporter
Oct 15 08:00 ETSource: ClinicalTrials.gov
The wire
- 01ClinicalTrials.gov entry NCT07874971, sponsored by Morten Hostrup, PhD, is not yet recruiting, with a listed start date of October 14, 2026.
- 02Clinicians fielding questions from lean, athletic patients have little data on how GLP-1 receptor agonists affect muscle mass and exercise capacity.
- 03The registration lists no enrollment or dose details in the posted record, and results from a short-term study in well-trained runners will not generalize to patients with obesity.
From the source
Read at clinicaltrials.govShort Term Effects of Semaglutide on Body Composition and Performance
NCT07874971 · NA · NOT YET RECRUITING · Sponsor: Morten Hostrup, PhD · Conditions: Caloric Restriction, Body Composition, Performance.
Source URL https://clinicaltrials.gov/study/NCT07874971
